News

Press Releases

• January 6, 2021

  Genesis Drug Discovery and Development expands its presence in the clinical space by acquiring STATKING Clinical Services

  View

• December 9, 2020

  Genesis Biotechnology Group announces second year of CRO relationship with Yale University

  View

• August 5, 2020

  Genesis Biotechnology Group acquires Comparative Biosciences, Inc. (CBI) to add GLP Toxicology and Safety Pharmacology to its portfolio of Preclinical Services

  View

• August 4, 2020

  Genesis Drug Discovery & Development (GD3) Announces Appointment of Anthony Rohr, as Chief Executive Officer of PharmOptima.

  View

• November 19, 2019

  Genesis Biotechnology Group acquires NEDP to grow the Preclinical Chemistry services portfolio of Genesis Drug Discovery & Development

  View

• June 18, 2019

  Genesis Drug Discovery & Development Expands Preclinical Contract Research Portfolio by Acquiring NexusPharma.

  View

• January 1, 2016

  EPO Berlin-Buch GmbH announces strategic partnership for the American market: EPO starts strategic collaboration with NexusPharma to foster its market position in the USA

  View